The goal of this clinical trial is to determine whether there are any interactions between the study drug and cocaine. Researchers will compare a treatment group and a placebo group to see if they experience any effects when administered cocaine after taking the treatment/placebo.
Phase:
PHASE1
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborators:
Altasciences Company Inc. Promentis Pharmaceuticals, Inc. Technical Resources International, Inc.